Exicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With Mcrpc).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.